Christian Loesche
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Acne and Rosacea Treatments and Effects, Hidradenitis Suppurativa and Treatments, Psoriasis: Treatment and Pathogenesis, Colorectal and Anal Carcinomas
Most-Cited Works
- → β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis(2016)232 cited
- → A comparison of the efficacy and tolerability of adapalene 0·1% gel versus tretinoin 0·025% gel in patients with acne vulgaris: a meta‐analysis of five randomized trials(1998)140 cited
- → Population Pharmacokinetic Modeling of Secukinumab in Patients With Moderate to Severe Psoriasis(2017)68 cited
- → Comparison of adapalene 0·1% solution and tretinoin 0·025% gel in the topical treatment of acne vulgaris(1998)63 cited
- → Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4(2020)56 cited
- → Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion(2015)48 cited
- → Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients(2010)47 cited
- → IL‐17A is a pertinent therapeutic target for moderate‐to‐severe hidradenitis suppurativa: Combined results from a pre‐clinical and phase II proof‐of‐concept study(2022)45 cited
- → Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: A randomized, multicenter, investigator-blinded, controlled study(2007)41 cited
- Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.(2001)